Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/0819 : 35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
2024/05/0819 : 35Edgar (US Regulatory)Form 8-K - Current reportNYSE:DCODucommun Inc
2024/05/0819 : 34Edgar (US Regulatory)Form 8-K - Current reportNYSE:NINisource Inc
2024/05/0819 : 34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPSCOMPASS Pathways PLC
2024/05/0819 : 33Edgar (US Regulatory)Form 8-K - Current reportNYSE:DINOHF Sinclair Corporation
2024/05/0819 : 33Edgar (US Regulatory)Form 8-K - Current reportNYSE:WWWWolverine World Wide Inc
2024/05/0819 : 33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:NXENexGen Energy Ltd
2024/05/0819 : 33Edgar (US Regulatory)Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).NYSE:BXSLBlackstone Secured Lending Fund
2024/05/0819 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:HMDCFHUTCHMED China Ltd (PK)
2024/05/0819 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HTHTH World Group Ltd
2024/05/0819 : 30Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLLL Flooring Holdings Inc
2024/05/0819 : 30GlobeNewswire Inc.Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorderTG:5Y6Compass Pathways Plc
2024/05/0819 : 30GlobeNewswire Inc.Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical ProgramNASDAQ:VERUVeru Inc
2024/05/0819 : 30GlobeNewswire Inc.Kraken Robotics Receives $3.5 Million of Orders for Subsea Security EquipmentTSXV:PNGKraken Robotics Inc
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaNYSE:TEVATeva Pharmaceutical Industries Ltd
2024/05/0819 : 30GlobeNewswire Inc.Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
2024/05/0819 : 30Business WireHF Sinclair Corporation Reports 2024 First Quarter Results and Announces Regular Cash DividendNYSE:DINOHF Sinclair Corporation
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaEU:MEDCLMedincell SA
2024/05/0819 : 30Business WireEaton to supply innovative ELocker differential system to leading electrified vehicle manufacturer
2024/05/0819 : 30GlobeNewswire Inc.Ducommun Incorporated Reports First Quarter 2024 ResultsNYSE:DCODucommun Inc
2024/05/0819 : 30Business WireAult Alliance’s Subsidiary, Sentinum, Completes Initial Bitcoin Mining Installation at Montana LocationAMEX:AULTAult Alliance Inc
2024/05/0819 : 30Business WireLubrizol Showcases LIPOFER™ Microencapsulation Technology, Introduces New EU Food-Grade Approval for Carbopol® Polymers at Vitafoods Europe 2024
2024/05/0819 : 30GlobeNewswire Inc.Azimut and SOQUEM Cut Very High Grade Lithium Drill Intercepts on Galinée, James Bay Region, QuebecTSXV:AZMAzimut Exploration Inc
2024/05/0819 : 30Business WireTeva et Medincell annoncent des résultats d'efficacité positifs pour l’essai de phase 3 SOLARIS de TEV-‘749 (olanzapine / mdc-TJK), injection sous-cutanée à action prolongée mensuelle pour les adultes atteints de schizophrénieEU:MEDCLMedincell SA
2024/05/0819 : 30Business WireWolverine Worldwide Appoints Taryn Miller as Chief Financial OfficerNYSE:WWWWolverine World Wide Inc
2024/05/0819 : 30Business WireTrane Technologies and the U.S. Department of Energy Partner to Advance Building Decarbonization in New Heat Pump Technology ChallengeNYSE:TTTrane Technologies plc
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaEU:MEDCLMedincell SA
2024/05/0819 : 30Business WireAmerican Clinical Research Services Announces Strategic Acquisition of Elixia
2024/05/0819 : 30Business WireTeva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with SchizophreniaEU:MEDCLMedincell SA
2024/05/0819 : 30GlobeNewswire Inc.Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorderNASDAQ:CMPSCOMPASS Pathways PLC

最近閲覧した銘柄

Delayed Upgrade Clock